A guidance offering recommendations and expectations on patient enrollment, reporting and evaluation of age-, race- and ethnicity-specific data in clinical studies of medical devices was finalized by the FDA. The document aims to promote the gathering and consideration of subgroups during a study's design stage, offer recommendations for reporting subgroup data in labeling and summaries for approved devices, and outline recommended subgroup data analyses.
FDA issues final guidance on subgroup data analysis, reporting in studies
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.